Literature DB >> 29801066

Association of Nodal Metastasis and Mortality With Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the Lip.

David M Wang1,2, Stefan Kraft3, Pooyan Rohani2, George F Murphy4, Robert J Besaw2, Pritesh S Karia2, Frederick C Morgan2, Chrysalyne D Schmults2.   

Abstract

Importance: Although the lip is considered a high-risk location in cutaneous squamous cell carcinoma (cSCC), it has not been established whether this risk stems from vermilion or cutaneous locations or both. Objective: To compare differences in risks of recurrence, metastasis, and death from cSCCs on the vermilion vs cutaneous lip. Design, Setting, and Participants: Retrospective cohort study of 303 patients with 310 primary cSCCs of the lip (138 cutaneous, 172 vermilion) diagnosed between 2000 and 2015 at 2 academic tertiary care centers in Boston, Massachusetts. Main Outcomes and Measures: Development of local recurrence, nodal metastasis, distant metastasis, disease-specific death, and all-cause death.
Results: Of the 303 study participants with 310 SCCs of the lip, 153 (50.5%) were men, and 150 (49.5%) were women; median age at diagnosis, 68 years (range, 27-93 years). Outcomes were as follows for vermilion vs cutaneous locations: local recurrence, 6.4% (11 of 172) vs 2.9% (4 of 138); nodal metastasis, 7.6% (13 of 172) vs 1.5% (2 of 138); distant metastasis, 0.6% (1 of 172) vs 0.7% (1 of 138); disease-specific death, 3.5% (6 of 172) vs 2.9% (4 of 138); and all-cause death, 26.7% (46 of 172) vs 29.0% (40 of 138). The difference was statistically significant for nodal metastasis (P = .01). In multivariable analysis, nodal metastasis was associated with vermilion lip location (subhazard ratio, 5.0; 95% CI, 1.1-23.8) and invasion beyond fat (fascia or beyond for vermilion lip) (subhazard ratio, 4.4; 95% CI, 1.3-14.9). Conclusions and Relevance: The risk of nodal metastasis is 5-fold greater for cSCCs on the vermilion lip compared with those on the cutaneous lip. Squamous cell carcinomas of the cutaneous lip have a nodal metastasis risk similar to cSCCs in general (1.5%). Thus, vermilion involvement appears responsible for the increased risk associated with cSCC of lip. Vermilion involvement may merit radiologic nodal staging and inclusion in future tumor staging, since it was independently associated with higher-risk cSCC of the lip region.

Entities:  

Mesh:

Year:  2018        PMID: 29801066      PMCID: PMC6145652          DOI: 10.1001/jamadermatol.2018.0792

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  16 in total

Review 1.  The epidemiology of UV induced skin cancer.

Authors:  B K Armstrong; A Kricker
Journal:  J Photochem Photobiol B       Date:  2001-10       Impact factor: 6.252

2.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.

Authors:  Howard W Rogers; Martin A Weinstock; Steven R Feldman; Brett M Coldiron
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

3.  Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.

Authors:  Michael J Veness; Gary J Morgan; Carsten E Palme; Val Gebski
Journal:  Laryngoscope       Date:  2005-05       Impact factor: 3.325

4.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 5.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

6.  Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.

Authors:  Anokhi Jambusaria-Pahlajani; Peter A Kanetsky; Pritesh S Karia; Wei-Ting Hwang; Joel M Gelfand; Faith M Whalen; Rosalie Elenitsas; Xiaowei Xu; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2013-04       Impact factor: 10.282

7.  Outcome analysis for lip carcinoma.

Authors:  R P Zitsch; C W Park; G J Renner; J L Rea
Journal:  Otolaryngol Head Neck Surg       Date:  1995-11       Impact factor: 3.497

8.  Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.

Authors:  Chrysalyne D Schmults; Pritesh S Karia; Joi B Carter; Jiali Han; Abrar A Qureshi
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

9.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.

Authors:  Kay D Brantsch; Christoph Meisner; Birgitt Schönfisch; Birgit Trilling; Jörg Wehner-Caroli; Martin Röcken; Helmut Breuninger
Journal:  Lancet Oncol       Date:  2008-07-09       Impact factor: 41.316

10.  Cutaneous squamous cell carcinoma of the lip: A population-based analysis.

Authors:  Aykut A Unsal; Aylin B Unsal; Tara E Henn; Soly Baredes; Jean Anderson Eloy
Journal:  Laryngoscope       Date:  2017-06-02       Impact factor: 3.325

View more
  3 in total

1.  Successful treatment of squamous cell carcinoma with intralesional methotrexate.

Authors:  L G Vega-González; M I Morales-Pérez; T Molina-Pérez; B Sereno-Gómez
Journal:  JAAD Case Rep       Date:  2022-04-26

Review 2.  Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.

Authors:  Aaron S Farberg; Alison L Fitzgerald; Sherrif F Ibrahim; Stan N Tolkachjov; Teo Soleymani; Leah M Douglas; Sarah J Kurley; Sarah T Arron
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-07

3.  The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.

Authors:  Erik Haehl; Alexander Rühle; Rabea Klink; Tobias Kalckreuth; Tanja Sprave; Eleni Gkika; Constantinos Zamboglou; Frank Meiß; Anca-Ligia Grosu; Nils H Nicolay
Journal:  Radiat Oncol       Date:  2021-06-12       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.